Evidence map›Paper›PMID 23407395›Full record

ArticleThe Journal of investigative dermatology2013

IL-1R1 signaling facilitates Munro's microabscess formation in psoriasiform imiquimod-induced skin inflammation.

Mireia Uribe-Herranz, Li-Hua Lian, Kirsten M Hooper, Katelynn A Milora, Liselotte E Jensen

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. FloxedCells · 2024
    Article
  10. Article
  11. Article
  12. IL-1Mediators of inflammation · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mireia Uribe-HerranzDepartment of Microbiology and Immunology and Temple Autoimmunity Center, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.
Li-Hua Lian
Kirsten M Hooper
Katelynn A Milora
Liselotte E Jensen
Temple University · US

Funding

Soluble IL-1RAcP proteins as inhibitors of inflammationR03AR053672 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI JENSEN, LISELOTTE E · 2007 to 2009
$232k
NIAMS NIH HHS AR053672NIAMS NIH HHS R03 AR053672
6 · The paper itself

Abstract

Munro's microabscesses contain polymorphonuclear leukocytes and form specifically in the epidermis of psoriasis patients. The mechanism whereby the neutrophils are recruited into the epidermis is poorly understood. Using a combination of human and mouse primary keratinocyte cell cultures and the imiquimod-induced psoriasis-like mouse model of skin inflammation, we explored the role of IL-1 signaling in microabscess formation. In vitro imiquimod stimulated production of IL-1α and neutrophil recruiting chemokines. Imiquimod-activated chemokine expression was dependent upon adenosine signaling and independent of IL-1α and IL-1 receptor type 1 (IL-1R1); nevertheless, IL-1α could enhance chemokine expression initiated by imiquimod. Topical application of imiquimod in vivo led to epidermal microabscess formation, acanthosis, and increased IL-1α and chemokine expression in the skin of wild-type mice. However, in IL-1R1-deficient mice these responses were either absent or dramatically reduced. These results demonstrate that IL-1α and IL-1R1 signaling is essential for microabscess formation, neutrophil recruiting chemokine expression, and acanthosis in psoriasis-like skin inflammation induced by imiquimod.

Indexed as

AbscessAdjuvants, ImmunologicAminoquinolinesAnimalsAnimals, NewbornChemokine CXCL1Chemokine CXCL2DermisDrug EruptionsEpidermal CellsHumansImiquimodInterleukin-1alphaInterleukin-1betaKeratinocytesMiceAdjuvants, ImmunologicAminoquinolinesChemokine CXCL1Chemokine CXCL2Cxcl1 protein, mouseCxcl2 protein, mouseImiquimodInterleukin-1alphaInterleukin-1betaReceptors, Interleukin-1 Type I

Identifiers

PMID23407395
PMCPMC3656131
OpenAlexW2066442488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.